Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...
AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical trial.
MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.
Alzheon Reports Plasma Biomarker Results from Phase 3 and 2 Studies of Valiltramiprosate/ALZ-801, Validating Its First-in-Class Mechanism of Action and Underscoring Benefits in Cognition, Function, ...
European study of 272,000 adults finds nighttime traffic noise above 50 dB linked to higher cholesterol and increased heart ...
The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...
Cognition Therapeutics, Inc. will present biomarker results from its Phase 2 SHINE study of zervimesine (CT1812) for mild-to-moderate Alzheimer's disease at the upcoming AD/PD 2025 Conference in ...
Researchers found a molecule that may forecast death in sepsis patients. The identification of this biomarker may aid clinicians in deciding whether to treat patients with therapies that either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results